Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 4;20(6):125.
doi: 10.1007/s11306-024-02185-0.

Multiplatform metabolomic interlaboratory study of a whole human stool candidate reference material from omnivore and vegan donors

Abraham Kuri Cruz  1 Marina Amaral Alves  2   3 Thorkell Andresson  4 Amanda L Bayless  5 Kent J Bloodsworth  6 John A Bowden  7 Kevin Bullock  8 Meagan C Burnet  6 Fausto Carnevale Neto  9 Angelina Choy  8 Clary B Clish  8 Sneha P Couvillion  6 Raquel Cumeras  10   11 Lucas Dailey  8 Guido Dallmann  12 W Clay Davis  5 Amy A Deik  8 Alex M Dickens  2   13 Danijel Djukovic  9 Pieter C Dorrestein  14 Josie G Eder  6 Oliver Fiehn  10 Roberto Flores  15 Helen Gika  16   17 Kehau A Hagiwara  5 Tuan Hai Pham  12 James J Harynuk  18 Juan J Aristizabal-Henao  7   19 David W Hoyt  6 Focant Jean-François  20 Matilda Kråkström  2 Amit Kumar  4 Jennifer E Kyle  6 Santosh Lamichhane  2 Yuan Li  21 Seo Lin Nam  18 Rupasri Mandal  22 A Paulina de la Mata  18 Michael J Meehan  14 Thomas Meikopoulos  15   17 Thomas O Metz  6 Thomai Mouskeftara  16   17 Nathalie Munoz  6 G A Nagana Gowda  9 Matej Orešic  2   23 Morgan Panitchpakdi  14 Stefanuto Pierre-Hugues  20 Daniel Raftery  9 Blake Rushing  21 Tracey Schock  5 Harold Seifried  4 Stephanie Servetas  24 Tong Shen  10 Susan Sumner  21 Kieran S Tarazona Carrillo  18 Dejong Thibaut  20 Jesse B Trejo  6 Lieven Van Meulebroek  25 Lynn Vanhaecke  25 Christina Virgiliou  16   17 Kelly C Weldon  14 David S Wishart  22 Lu Zhang  22 Jiamin Zheng  22 Sandra Da Silva  26
Affiliations

Multiplatform metabolomic interlaboratory study of a whole human stool candidate reference material from omnivore and vegan donors

Abraham Kuri Cruz et al. Metabolomics. .

Abstract

Introduction: Human metabolomics has made significant strides in understanding metabolic changes and their implications for human health, with promising applications in diagnostics and treatment, particularly regarding the gut microbiome. However, progress is hampered by issues with data comparability and reproducibility across studies, limiting the translation of these discoveries into practical applications.

Objectives: This study aims to evaluate the fit-for-purpose of a suite of human stool samples as potential candidate reference materials (RMs) and assess the state of the field regarding harmonizing gut metabolomics measurements.

Methods: An interlaboratory study was conducted with 18 participating institutions. The study allowed for the use of preferred analytical techniques, including liquid chromatography-mass spectrometry (LC-MS), gas chromatography-mass spectrometry (GC-MS), and nuclear magnetic resonance (NMR).

Results: Different laboratories used various methods and analytical platforms to identify the metabolites present in human stool RM samples. The study found a 40% to 70% recurrence in the reported top 20 most abundant metabolites across the four materials. In the full annotation list, the percentage of metabolites reported multiple times after nomenclature standardization was 36% (LC-MS), 58% (GC-MS) and 76% (NMR). Out of 9,300 unique metabolites, only 37 were reported across all three measurement techniques.

Conclusion: This collaborative exercise emphasized the broad chemical survey possible with multi-technique approaches. Community engagement is essential for the evaluation and characterization of common materials designed to facilitate comparability and ensure data quality underscoring the value of determining current practices, challenges, and progress of a field through interlaboratory studies.

Keywords: Fecal matter; Gut metabolomics; Human stool; Lipidomics; Metabolomics; Multiplatform analysis; Reference materials.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest

PCD consulted for DSM animal Health in 2023, is an advisor and holds equity in Cybele and scientific co-founder and holds equity in Enveda, Arome and Ometa with prior approval by UC-San Diego. All other authors declared no financial or proprietary interests in any material discussed in this article.

Figures

Fig. 1
Fig. 1
Data Analysis Workflow
Fig. 2
Fig. 2
Frequency of metabolites (full list) reported by participants using LC-MS. The table denotes how often a metabolite was reported across participants. For instance, four metabolites were similarly reported by 12 participants while no common metabolites (zero) were reported across all 14 participants.
Fig. 3
Fig. 3
Frequency (%) of annotated metabolites reported before (A) and after (B) nomenclature standardization by RefMet. The colors indicate the frequency of metabolites reported, ranging from one to ten times. For reference, before standardization 47.4%, 42.2%, 47% and 46% of metabolites were reported one time across all samples (blue). After nomenclature standardization these values were 60.5%, 58.7%, 62.4% and 62.8% respectively, showing a higher frequency of multiple reported metabolites.
Fig. 4
Fig. 4
Frequency of annotated metabolites (full list, 875 total) reported by participants using GC-MS. The table denotes the number of times a metabolite was reported across participants. For instance, 16 metabolites were reported by five participants, while no single metabolite was consistently reported by all six participants. For example, 21% of metabolites (92 unique metabolites) were reported by two datasets.
Fig. 5
Fig. 5
Frequency of annotated metabolites (full list, 246 total) reported by participants using NMR. The table shows how often metabolites were recorded across participants. For instance, nine unique metabolites were reported by all five participants and 16% of metabolites were reported by three datasets.

References

    1. Alseekh S, Aharoni A, Brotman Y, Contrepois K, D’Auria J, Ewald J, Ewald CJ, Fraser PD, Giavalisco P, Hall RD, Heinemann M, Link H, Luo J, Neumann S, Nielsen J, Perez de Souza L, Saito K, Sauer U, Schroeder FC, … Fernie AR (2021). Mass spectrometry-based metabolomics: a guide for annotation, quantification and best reporting practices. Nature Methods (Vol. 18, Issue 7, pp. 747–756). Nature Research. 10.1038/s41592-021-01197-1 - DOI - PMC - PubMed
    1. Aristizabal-Henao JJ, Lemas DJ, Griffin EK, Costa KA, Camacho C, & Bowden JA (2021). Metabolomic Profiling of Biological Reference Materials using a Multiplatform High-Resolution Mass Spectrometric Approach. Journal of the American Society for Mass Spectrometry, 32(9), 2481–2489. 10.1021/jasms.1c00194 - DOI - PubMed
    1. Bang G, Park JH, Park C, Kim K. joong, Kim JK, Lee SY, Kim JY, & Park YH (2022). High-resolution metabolomics-based biomarker discovery using exhaled breath condensate from patients with lung cancer. Journal of Analytical Science and Technology, 13(1). 10.1186/s40543-022-00347-0 - DOI
    1. Barandouzi ZA, Lee J, del Carmen Rosas M, Chen J, Henderson WA, Starkweather AR, & Cong XS (2022). Associations of neurotransmitters and the gut microbiome with emotional distress in mixed type of irritable bowel syndrome. Scientific Reports, 12(1). 10.1038/s41598-022-05756-0 - DOI - PMC - PubMed
    1. Bayless A, Da Silva S, Davis WC, Kuri Cruz A, Piotrowski P, Schock T, & Servetas S (2023). Multi’omic Characterization of Human Whole Stool RGTMs. NIST Internal Report (IR) 8451. 10.6028/NIST.IR.8451 - DOI